Supporting Blood Cancer Clinical Trials: Predicting Study Challenges

What challenges should teams conducting blood cancer clinical trials anticipate? Learn more about common obstacles and how to overcome them.

May 26, 2022
View the Post

Ensuring Consistency in RECIST 1.1 Reads

RECIST criteria is not always reported accurately, and variability in tumor response assessment may be disastrous for measuring true treatment effect. Here’s how your CRO can support more consistent RECIST reads.

December 15, 2021
View the Post

Breast Cancer Clinical Trials: A Caregiver & Project Manager’s Perspective

Breast Cancer Clinical Trials: A Caregiver, Advocate, and Project Manager’s Perspective  “Being an advocate for my mother made a big difference,” Tamara said. “Some people might be going through this process alone, or may not be able to understand the whole disease. I feel I was fortunate to be able to put my oncology background...
November 15, 2021
View the Post

Immuno-Oncology Clinical Trial Considerations

What do you need to consider when managing/monitoring an immuno-oncology clinical trial? Download PharPoint’s fact book to learn more.

May 5, 2021
View the Post

Acknowledging World Cancer Day 2021

February 4th marks World Cancer Day, led by the Union for International Cancer Control (UICC). As a CRO with expertise in oncology, PharPoint Research is dedicated to uniting in the fight against cancer.

February 4, 2021
View the Post